Atlas Trials

Urinary Bladder Cancer, Muscle-invasive

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Urinary Bladder Cancer, Muscle-invasive

RecordFirmDate
Perioperative Pembrolizumab (MK-3475) Plus Cystectomy or Perioperative Pembrolizumab Plus Enfortumab Vedotin Plus Cystectomy Versus Cystectomy Alone in Participants Who Are Cisplatin-ineligible or Decline Cisplatin With Muscle-invasive Bladder Cancer (MK-3475-905/KEYNOTE-905/EV-303) (NCT03924895)Merck Sharp & Dohme LLC2019-07-24

Track Urinary Bladder Cancer, Muscle-invasive automatically

Every clearance here is in the API, with alerts when new ones post.